Clinical Trials Browser

Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, Hemorrhagic Disorders, Immune System Diseases, Immunoproliferative Disorders, Lymphoproliferative Disorders, Multiple Myeloma, Neoplasms, Neoplasms by Histologic Type, Paraproteinemias, Vascular Diseases, Hemostatic Disorders, Neoplasms, Plasma Cell

NCT04657120 2025-12-23

HYDRA

Phase NA Completed

698 enrolled

Cardiovascular Diseases, Disease, Embolism, Lung Diseases, Neoplasms, Pulmonary Embolism, Respiratory Tract Diseases, Vascular Diseases, Embolism and Thrombosis

NCT02831556 2024-05-21

Point of Care 3D Ultrasound for Various Applications: A Pilot Study

Completed

174 enrolled

GastrointestinalGenitourinaryGynecologic

Abdominal Injuries, Aortic Aneurysm, Appendicitis, Digestive System Diseases, Diverticulitis, Gastrointestinal Diseases, Intestinal Diseases, Kidney Calculi, Leiomyoma, Neoplasms, Ovarian Cysts, Pancreatitis, Polyps, Pregnancy, Ectopic, Vascular Diseases, Gallstones, Intraabdominal Infections

NCT04999618 2021-11-04

DOUBLE-SKIN

Phase 4 Completed

200 enrolled

Capillary Malformations, Congenital, 1, Capillary Malformation-Arteriovenous Malformation, Sturge-Weber Syndrome, Vascular Diseases, Vascular Neoplasms, Port-Wine Stain, Vascular Malformations

NCT04142710 2021-10-07

MAO

Phase NA Completed

732 enrolled

Mental Disorders, Chronic Disease, Diabetes Mellitus, Neoplasms, Vascular Diseases

NCT00773747 2021-04-30

Study of Vorinostat (MK-0683) or Placebo, in Combination With Bortezomib in Participants With Multiple Myeloma (MK-0683-088 AMN)

Phase 3 Completed

637 enrolled 15 charts

LymphoidPlasma cell

Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, Hemorrhagic Disorders, Immune System Diseases, Immunoproliferative Disorders, Lymphoproliferative Disorders, Multiple Myeloma, Neoplasms, Neoplasms by Histologic Type, Paraproteinemias, Vascular Diseases, Hemostatic Disorders, Neoplasms, Plasma Cell

NCT03099031 2019-12-16

PREDICARE

Completed

420 enrolled

BreastClassical hematologyGastrointestinalGenitourinaryLymphoidMyeloidOther hematologic neoplasmPlasma cellThoracic

Breast Neoplasms, Digestive System Neoplasms, Intestinal Neoplasms, Leukemia, Lung Neoplasms, Lymphatic Diseases, Lymphoma, Lymphoproliferative Disorders, Multiple Myeloma, Myeloproliferative Disorders, Neoplasms, Prostatic Neoplasms, Thromboembolism, Urogenital Neoplasms, Vascular Diseases, Colorectal Neoplasms, Hemostatic Disorders, Venous Thrombosis, Venous Thromboembolism

NCT04154761 2019-11-08

CAVARESECT

Completed

13 enrolled

Neoplasms, Vascular Diseases

NCT00079716 2014-12-18

Study of SGN-40 in Patients With Refractory or Recurrent Multiple Myeloma

Phase 1 Completed

44 enrolled

LymphoidPlasma cell

Blood Coagulation Disorders, Hematologic Diseases, Hemorrhagic Disorders, Immunoproliferative Disorders, Lymphoproliferative Disorders, Multiple Myeloma, Paraproteinemias, Vascular Diseases, Hemostatic Disorders

NCT00525447 2014-10-09

Study of SGN-40, Lenalidomide, and Dexamethasone in Patients With Multiple Myeloma

Phase 1 Completed

36 enrolled

LymphoidPlasma cell

Blood Coagulation Disorders, Hematologic Diseases, Hemorrhagic Disorders, Immunoproliferative Disorders, Lymphoproliferative Disorders, Multiple Myeloma, Paraproteinemias, Vascular Diseases, Hemostatic Disorders

NCT00725634 2014-01-27

P05538

Phase 1 Completed

41 enrolled

LymphoidPlasma cell

Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, Hemorrhagic Disorders, Immunoproliferative Disorders, Lymphatic Diseases, Lymphoma, Lymphoproliferative Disorders, Multiple Myeloma, Neoplasms, Neoplasms by Histologic Type, Paraproteinemias, Vascular Diseases, Neoplasms, Plasma Cell

NCT00000479 2012-06-15

WHS

Phase 3 Completed

39,876 enrolled 11 charts

Cardiovascular Diseases, Cerebrovascular Disorders, Coronary Disease, Heart Diseases, Myocardial Infarction, Vascular Diseases, Myocardial Ischemia

Clinical Trials

A Study of Elranatamab (PF-06863135) in Chinese Participants With Refractory Multiple Myeloma.

HYDRA

Point of Care 3D Ultrasound for Various Applications: A Pilot Study

DOUBLE-SKIN

MAO

Study of Vorinostat (MK-0683) or Placebo, in Combination With Bortezomib in Participants With Multiple Myeloma (MK-0683-088 AMN)

PREDICARE

CAVARESECT

Study of SGN-40 in Patients With Refractory or Recurrent Multiple Myeloma

Study of SGN-40, Lenalidomide, and Dexamethasone in Patients With Multiple Myeloma

P05538

WHS